GONZALEZ-RIVAS, Juan P., Iuliia PAVLOVSKA, Anna POLCROVÁ, Ramfis NIETO-MARTINEZ and Jeffrey I. MECHANICK. Transcultural Lifestyle Medicine in Type 2 Diabetes Care: Narrative Review of the Literature. AMERICAN JOURNAL OF LIFESTYLE MEDICINE. THOUSAND OAKS: SAGE PUBLICATIONS INC, 2023, vol. 17, No 4, p. 518-559. ISSN 1559-8276. Available from: https://dx.doi.org/10.1177/15598276221095048.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Transcultural Lifestyle Medicine in Type 2 Diabetes Care: Narrative Review of the Literature
Authors GONZALEZ-RIVAS, Juan P. (guarantor), Iuliia PAVLOVSKA (804 Ukraine, belonging to the institution), Anna POLCROVÁ (203 Czech Republic, belonging to the institution), Ramfis NIETO-MARTINEZ and Jeffrey I. MECHANICK.
Edition AMERICAN JOURNAL OF LIFESTYLE MEDICINE, THOUSAND OAKS, SAGE PUBLICATIONS INC, 2023, 1559-8276.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30304 Public and environmental health
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 1.900 in 2022
RIV identification code RIV/00216224:14110/23:00130012
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1177/15598276221095048
UT WoS 000806385700001
Keywords in English dysglycemia; culture; lifestyle medicine; prevention; transcultural; type 2 diabetes
Tags 14110525, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 26/1/2024 10:10.
Abstract
Disparities in type 2 diabetes (T2D) care is a global problem across diverse cultures. The Dysglycemia-Based Chronic Disease (DBCD) model promotes early and sustainable interventions along the insulin resistance (stage 1), prediabetes (stage 2), T2D (stage 3), and complications (stage 4) spectrum. In this model, lifestyle medicine is the cornerstone of preventive care to reduce DBCD progression and the socioeconomic/biological burden of disease. A comprehensive literature review, spanning 2000 to 2021, was performed and 55 studies were included examining the effects of lifestyle medicine and their cultural adaptions with different prevention modalities. In stage 1, primordial prevention targets modifiable primary drivers (behavior and environment), unhealthy lifestyles, abnormal adiposity, and insulin resistance with educational and motivational health promotion activities at individual, group, community, and population-based scales. Primary, secondary, and tertiary prevention targets individuals with mild hyperglycemia, severe hyperglycemia, and complications, respectively, using programs that incorporate structured lifestyle interventions. Culturally adapted lifestyle change in primary and secondary prevention improved quality of life and biomarkers, but with a limited impact of tertiary prevention on cardiovascular events. In conclusion, lifestyle medicine with cultural adaptations is an integral part of preventive care in patients with T2D. However, considerable research gaps exist, especially for tertiary prevention.
PrintDisplayed: 19/7/2024 22:20